36739463|t|Nicotine exposure decreases likelihood of SARS-CoV-2 RNA expression and neuropathology in the hACE2 mouse brain but not moribundity.
36739463|a|Individuals infected by SARS-CoV-2 are at risk of developing neurological-related post-acute disorders. Disputed epidemiological data indicated nicotine may reduce the severity of infection. Here we find exposure to nicotine in drinking water does not alter the moribundity of hACE2 mice. However, pre-exposure to nicotine decreased the likelihood of SARS-CoV-2 RNA expression and pathology in the brain. These results suggest mechanisms involving targets of nicotine could be leveraged to prevent the neurovirulence of SARS-CoV-2.
36739463	0	8	Nicotine	Chemical	MESH:D009538
36739463	42	52	SARS-CoV-2	Species	2697049
36739463	72	86	neuropathology	Disease	MESH:D009422
36739463	100	105	mouse	Species	10090
36739463	157	167	SARS-CoV-2	Species	2697049
36739463	194	235	neurological-related post-acute disorders	Disease	MESH:D013313
36739463	277	285	nicotine	Chemical	MESH:D009538
36739463	313	322	infection	Disease	MESH:D007239
36739463	349	357	nicotine	Chemical	MESH:D009538
36739463	416	420	mice	Species	10090
36739463	447	455	nicotine	Chemical	MESH:D009538
36739463	484	494	SARS-CoV-2	Species	2697049
36739463	592	600	nicotine	Chemical	MESH:D009538
36739463	653	663	SARS-CoV-2	Species	2697049
36739463	Negative_Correlation	MESH:D009538	MESH:D009422
36739463	Negative_Correlation	MESH:D009538	MESH:D007239

